the advantage that LCT has over that study (puting aside the small singular 4 patients) is this:
"NTCELL’s ability to decrease UPDRS by an average of 14 points after 81 weeks is clinically significant, representing a 2.8 to 3.5 year reversal of neurological deterioration. In the first patient the improvement is sustained at 130 weeks after NTCELL implant."
http://www.businesswire.com/news/ho...ogies-NTCELL®-Demonstrates-Continued-Reversal
![]()
you get bonus points if your study had multiple placebo at 81 weeks too !!
- Forums
- ASX - By Stock
- 1AI
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-10
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AI (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M |
Open | High | Low | Value | Volume |
0.7¢ | 0.8¢ | 0.7¢ | $6.268K | 895.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 4707556 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 1255620 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 4707556 | 0.007 |
9 | 2486749 | 0.006 |
8 | 6510009 | 0.005 |
6 | 7865000 | 0.004 |
1 | 600000 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 1255620 | 12 |
0.009 | 2278303 | 12 |
0.010 | 2350288 | 3 |
0.011 | 1490400 | 3 |
0.012 | 363666 | 3 |
Last trade - 15.50pm 12/09/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |